Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Lunch and Poster Display session

37P - Employing semi-quantitative methods to classify breast cancer markers (ER, PR, HER2, Ki67) expression using the RT-qPCR based APIS breast cancer subtyping kit

Date

16 May 2024

Session

Lunch and Poster Display session

Presenters

Joanna Gorniak

Citation

Annals of Oncology (2024) 9 (suppl_4): 1-34. 10.1016/esmoop/esmoop103010

Authors

J. Gorniak1, A. Wegscheider2, A. Gasior1, K.J. Howard1, L. Gough1, M. Harrison1, S. Rollinson1, Z. Pounce1, A. Niendorf2

Author affiliations

  • 1 Apis Assay Technologies Ltd, Manchester/GB
  • 2 MVZ Prof. Dr. med. A. Niendorf Pathologie Hamburg-West GmbH, Hamburg/DE

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 37P

Background

Accurate determination of breast cancer (BC) biomarker status is crucial for guiding patient management decisions. Histopathologists commonly use semi-quantitative scoring systems to convert subjective observations of immunohistochemistry (IHC) marker expression into quantitative data. The APIS Breast Cancer Subtyping Kit (BCSK) detects the relative expression of mRNA target genes from invasive BC tissue. The APIS BCSK reports a positive/negative result for each biomarker alongside a molecular classification. Here, we demonstrate that by implementing additional RNA expression cut-off values, it is possible to generate a semi-quantitative result by further stratifying target expression using the APIS BCSK.

Methods

368 formalin-fixed paraffin-embedded (FFPE) samples were used. IHC scores were correlated with copy numbers as determined by digital PCR (dPCR) and were used to set copy number cut-off values corresponding to IHC classification. Generated dPCR cut-off values were used to evaluate the corresponding ΔCt values (RNA expression results derived from the APIS BCSK.

Results

The semi-quantitative approach successfully classified target expression levels. Three ΔCt cut-offs were established, facilitating classification into negative, low, medium, and high expression. Overlap in ΔCt values was observed in central IHC categories for all targets, likely due to tumor heterogeneity. Despite these discrepancies, the derived cut-off values define a semi-quantitative scale for each target (Table). Table: 37P

Summary of individual target bin,ΔCt range and category

Target Lower ΔCt limit Upper ΔCt limit Expression classification
ESR1 - <-2.162 Negative
-2.162 0.115 Low
0.115 1.215 Medium
>1.215 - High
PGR - <-0.376 Negative
-0.376 1.214 Low
1.214 2.867 Medium
>2.867 - High
ERBB2 - <1.080 Negative
1.08 1.403 Low
1.403 2.054 Medium
>2.054 - High
MKI67 - <-1.265 Negative
-1.265 -0.401 Low
-0.401 0.417 Medium
>0.417 - High

Conclusions

This study has established a methodology that utilises target copy number values and IHC quantification to establish ΔCt cut-off points. With this approach, we have defined four distinct classifications, providing a semi-quantitative scale for evaluating targets with the APIS BCSK.

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.